pinched this link from another thread, interesting connections with Neu especially with Oral TBI and ASD trials coming soon.
"If companies are able to conduct a single, robust Phase I clinical trial, Woodock said, a drug could very well see approval based on that data.
"We expect many of these would come available very quickly with Phase 1 data,” Bloomberg reported Woodcock as saying."
http://www.raps.org/focus-online/news/news-article-view/article/2853/woodcock-fda-to-consider-approving-some-drugs-using-just-one-phase-i-clinical-t.aspx
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$14.20 |
Change
0.890(6.69%) |
Mkt cap ! $1.761B | |||
| Open | High | Low | Value | Volume |
| $13.50 | $14.26 | $12.96 | $9.111M | 655.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | $14.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.23 | 3278 | 1 |
View Market Depth
| Last trade - 16.15pm 27/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |